Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Anti-KRAS G12D TCR cells |
Synonyms | |
Therapy Description |
Anti-KRAS G12D TCR cells are autologous T-cells engineered to express HLA-C*08:02-restricted T-cell receptors (TCR) targeting KRAS G12D, potentially leading to inhibition of tumor growth (PMID: 35648703). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Anti-KRAS G12D TCR cells | Anti-KRAS G12D T-cell receptor cells | Anti-KRAS G12D TCR cells are autologous T-cells engineered to express HLA-C*08:02-restricted T-cell receptors (TCR) targeting KRAS G12D, potentially leading to inhibition of tumor growth (PMID: 35648703). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|